Background: Trichotillomania (TTM) is a complex disease with varying clinical characteristics, and psychosocial impairment is noted in many TTM patients. Despite its prevalence in childhood, there is limited research on pediatric TTM. Objective: To analyze the clinical and epidemiologic features of TTM in children evaluated by dermatologists and behavioral health specialists. Method: We performed a retrospective chart review of 137 pediatric patients seen at the Children’s Hospital of Philadelphia with initial presentation of TTM at age 17 or younger. Patients were treated by dermatology or behavioral health. Results: The majority of the patients were females, with an average diagnosis age around 8 years. Over half had a psychiatric comorbidity, and over a quarter had a skin disorder. Skin disorders were more commonly present in those evaluated by dermatology, and psychiatric comorbidities were more commonly present in those evaluated by behavioral health. The most common form of treatment was behavioral therapy, with medications prescribed more often by dermatologists. Conclusions: TTM patients choose to present to behavioral health or dermatology; however, there are distinctive differences between the two cohorts. With behavioral and pharmacologic treatment options, a relationship between dermatologists and behavioral health specialists is necessary for multifactorial management of TTM.

1.
Hallopeau
M
.
Alopecie par grattage (trichomanie ou trichotillomanie)
.
Ann Dermatol Syphil
.
1889
;
10
:
440
1
.
2.
Substance Abuse and Mental Health Services Administration. Impact of the DSM-IV to DSM-5 changes on the National Survey on Drug Use and Health [Internet]. Rockville (MD): Substance Abuse and Mental Health Services Administration (US) [cited 2016 June]. Table 3.27, DSM-IV to DSM-5 Trichotillomania (Hair-Pulling Disorder) Comparison. Available from
: https://www.ncbi.nlm.nih.gov/books/NBK519704/table/ch3.t27/
3.
O’Sullivan
RL
,
Keuthen
NJ
,
Christenson
GA
.
Trichotillomania: behavioral symptom or clinical syndrome?
Am J Psychiatry
.
1997
;
154
:
1442
9
.
4.
Sperling
LC
,
Mezebish
DS
.
Hair diseases
.
Med Clin North Am
.
1998
;
82
(
5
):
1155
69
. .
5.
Ricketts
EJ
,
Snorrason
I
,
Kircanski
K
,
Alexander
JR
,
Stiede
JT
,
Thamrin
H
, et al.
A latent profile analysis of age of onset in trichotillomania
.
Ann Clin Psychiatry
.
2019 Aug
;
31
(
3
):
169
78
.
6.
Christenson
GA
,
Pyle
RL
,
Mitchell
JE
.
Estimated lifetime prevalence of trichotillomania in college students
.
J Clin Psychiatry
.
1991
;
52
(
10
):
415
7
.
7.
Bouwer
C
,
Stein
DJ
.
Trichobezoars in trichotillomania: case report and literature overview
.
Psychosom Med
.
1998
;
60
(
5
):
658
60
. .
8.
Harrison
JP
,
Franklin
ME
.
Pediatric trichotillomania
.
Curr Psychiatry Rep
.
2012
;
14
(
3
):
188
96
. .
9.
Henkel
ED
,
Jaquez
SD
,
Diaz
LZ
.
Pediatric trichotillomania: review of management
.
Pediatr Dermatol
.
2019 Nov
;
36
(
6
):
803
7
. .
10.
Woods
DW
,
Flessner
CA
,
Franklin
ME
,
Keuthen
NJ
,
Goodwin
RD
,
Stein
DJ
, et al.
The trichotillomania impact project (TIP): exploring phenomenology, functional impairment, and treatment utilization
.
J Clin Psychiatry
.
2006
;
67
(
12
):
1877
88
. .
11.
Klobucar
A
,
Folnegovic-Smalc
V
,
Folnegovic-Smalc
V
,
Kocijan-Hercigonja
D
,
Sovic
S
,
Gulic
L
.
Clinical characteristics and comorbidity of pediatric trichotillomania: the study of 38 cases in Croatia
.
Psychiat Danub
.
2018
;
30
(
1
):
79
84
. .
12.
Antunes
H
,
Barroso
C
,
Faria
C
,
Correia-Pinto
J
.
Images in paediatrics: Rapunzel syndrome: the pathway for a prompt diagnosis
.
Arch Dis Child
.
2020 Mar
;
105
(
3
):
298
. .
13.
Kinoo
SM
,
Singh
B
.
Gastric trichobezoar: an enduring intrigue
.
Case Rep Gastrointest Med
.
2012
;
2012
:
136963
.
14.
Farhat
LC
,
Olfson
E
,
Levine
JLS
,
Li
F
,
Franklin
ME
,
Lee
HJ
, et al.
Measuring treatment response in pediatric trichotillomania: a meta-analysis of clinical trials
.
J Child Adolesc Psychopharmacol
.
2019 Dec 2
;
30
(
5
):
306
15
.
Epub ahead of print
.
15.
Association for Behavioral and Cognitive Therapies [Internet]. ABCT Trichotillomania Fact Sheet [cited 2020]. Available from http://www.abct.org/docs/factsheets/TRICHOTILLOMANIA.pdf
.
16.
Castelo-Soccio
L
,
McMahon
P
.
Pediatric dermatology
.
J Clin Aesthet Dermatol
.
2017 Mar
;
10
(
3
):
S8
15
.
17.
Chandran
NS
,
Novak
J
,
Iorizzo
M
,
Grimalt
R
,
Oranje
AP
.
Trichotillomania in children
.
Skin Appendage Disord
.
2015
;
1
(
1
):
18
24
. .
18.
Flessner
CA
.
Cognitive-behavioral therapy for childhood repetitive behavior disorders: tic disorders and trichotillomania
.
Child Adolesc Psychiatr Clin N Am
.
2011
;
20
(
2
):
319
28
. .
19.
Tracey
EH
.
Challenges of treating primary psychiatric disease in dermatology
.
Cutis
.
2019 Aug
;
104
(
2
):
E12
14
..
20.
Carr
JM
,
Mortimer
H
,
Martin
K
,
Kaur
M
,
Goulding
JMR
.
A retrospective review of 12 patients with trichotillomania treated in a psychodermatology service
.
Clin Exp Dermatol
.
2019 Aug
;
44
(
6
):
658
60
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.